ADAG vs JBIO

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 14, 2026

ADAG

46.3
AI Score
VS
ADAG Wins

JBIO

36.8
AI Score

Investment Advisor Scores

ADAG

46score
Recommendation
HOLD

JBIO

37score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric ADAG JBIO Winner
Net Income -17.61M -96.13M ADAG
Operating Income -21.44M -102.36M ADAG
ROE -49.8% -21.9% JBIO
ROA -22.5% -20.4% JBIO
Total Assets 78.26M 472.11M JBIO
Cash 74.52M 107.25M JBIO
Current Ratio 3.07 14.93 JBIO

Relative Price Performance (Last 90 Days)

ADAG 1M: +19.3% · 3M: +6.1% JBIO 1M: +8.8% · 3M: -9.0%

Current Technical Phase

ADAG

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.0% over 20 days), RSI 55

RSI (14): 55.1 · Price: $4.02

JBIO

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 48

RSI (14): 47.5 · Price: $21.34

Fundamentals Snapshot

Metric ADAG JBIO
Market Cap
Forward P/E -7.2 -8.0
Trailing P/E
Revenue (TTM)
Revenue Growth 73.3% 0.0%
Gross Margin 1.0%
Operating Margin -10.2% 0.0%
EPS -0.37 -1.01
Dividend Yield

Frequently Asked Questions

Based on our detailed analysis, ADAG is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.